Earth Science Tech (ETST) Liabilities and Shareholders Equity (2012 - 2026)
Earth Science Tech's (ETST) quarterly Liabilities and Shareholders Equity came in at $9.0 million in Q1 2026, up 26.92% YoY from $7.1 million in Q1 2025, and up 10.88% on a QoQ basis from $8.1 million in Q4 2025.
Earth Science Tech (ETST) Liabilities and Shareholders Equity (2012 - 2026) Analysis & Trends
Earth Science Tech (ETST) has 13 years of Liabilities and Shareholders Equity data on file, last reported at $9.0 million in Q1 2026.
- Quarterly Liabilities and Shareholders Equity rose 26.92% year-over-year to $9.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $33.5 million (up 48.28% YoY) and the FY2026 annual result came in at $9.0 million, up 26.92% from the prior year.
- Liabilities and Shareholders Equity climbed to $9.0 million in Q1 2026, from $8.1 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $9.0 million in Q1 2026 to a low of $76942.0 in Q1 2022.
- A 5-year average of $4.3 million and a median of $3.9 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
- Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity grew 19.17% — and 2023, when it soared 3445.49%.
- Tracing ETST's Liabilities and Shareholders Equity over 5 years: stood at $537376.0 in 2022, then jumped by 511.1% to $3.3 million in 2023, then soared by 73.82% to $5.7 million in 2024, then soared by 41.72% to $8.1 million in 2025, then gained by 10.88% to $9.0 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $9.0 million (Q1 2026), $8.1 million (Q4 2025), and $8.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 43.71 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 39.86 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 15.08 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 98.27 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 7.22 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 35.04 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 5.36 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 13.56 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 6.18 Bn |
| 10 | Earth Science Tech | 34.80 Mn | 31.98 Mn | 6.28 Mn | 10.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.37 Mn |
| Mar 31, 2026 | 8.97 Mn |
| Dec 31, 2025 | 8.09 Mn |
| Sep 30, 2025 | 8.67 Mn |
| Jun 30, 2025 | 7.78 Mn |
| Mar 31, 2025 | 7.07 Mn |
| Dec 31, 2024 | 5.71 Mn |
| Sep 30, 2024 | 5.05 Mn |
| Jun 30, 2024 | 4.77 Mn |
| Mar 31, 2024 | 3.88 Mn |
| Dec 31, 2023 | 3.28 Mn |
| Sep 30, 2023 | 3.08 Mn |
| Jun 30, 2023 | 2.95 Mn |
| Mar 31, 2023 | 2.73 Mn |
| Dec 31, 2022 | 537,376.00 |
| Sep 30, 2022 | 355,762.00 |
| Jun 30, 2022 | 320,323.00 |
| Mar 31, 2022 | 76,942.00 |
| Dec 31, 2021 | 25,680.00 |
| Sep 30, 2021 | 53,525.00 |